LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Cyclopentanohydrophenanthrene ring system doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

6.alpha.-Methylprednisolone derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

7 &agr;-(5-methylaminopentyl)-estratrienes, process for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

7-Oxo-DHEA compounds for treating keratinous...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

7.alph a.-Acylthio-15,16-methylene-3-oxo-17.alpha.-pregna-1,4-di

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their produ

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

7.alpha.-Acylthio-1.alpha.,2.alpha.-methylene- 3-oxo-17.alpha.-p

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

7.alpha.-Substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolact

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

8β-hydrocarbyl-substituted estratrienes for use as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

8β-hydrocarbyl-substituted estratrienes for use as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

8β-vinyl-11β-(ω-substituted)alkyl-estra-1,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

9 alpha, 11 beta-substituted and 11 beta-substituted estranes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

9-α-substituted estratrienes as selectively active...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

9.alpha., 11.beta.-substituted and 11.beta.-substituted estranes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

9.alpha.-hydroxy-3-oxo-4,24(25)-stigmastadien-26-oic acid deriva

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

Acid addition salts of amidated taurine or glycine, their prepar

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

Activation of androgen receptors with low dose non-masculinizing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

Administration of a 27-hydroxycholesterol or prodrug thereof as

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

Administration of a 27-hydroxycholesterol or related compound or